Amendment__2-_BAA-NIAID-DAIT-NIHAI2013167.pdf

Amendment #2 to BAA-NIAID-DAIT-NIHAI2013167 Large Scale T Cell Epitope Discovery

Amendment to Solicitation No.: BAA-NIAID-DAIT-NIHAI2013167

Amendment No.: 2

Issue Date: July 23, 2013

Effective Date:

Proposal Due Date:

July 23, 2013

October 01, 2013 at 3:00 P.M. local time

Issued By: Tom Bahrami, MBA Contracting Officer

NIH/NIAID

Office of Acquisitions 6700 B Rockledge Drive Room 3109 Bethesda, Maryland 20892-7612

Point of Contact: Brandon de White, Contract Specialist whitebra@niaid.nih.gov

Name and Address of Offeror: To All Potential Offerors

The above numbered solicitation is amended as set forth below. The hour and date specified for receipt of proposals remains unchanged. Offerors must acknowledge receipt of this amendment. Failure to receive your acknowledgement of this amendment may result in the rejection of your offer.

SECTION 1 – AMENDMENTS TO THE SOLICITATION

This section of the amendment provides modifications to the above referenced solicitation. All of other terms and conditions of the solicitation remain unchanged.

Item 1: Solicitation BAA-NIAID-DAIT-NIHAI2013167 does not appear to include a link to Section K in “SECTION J – List of Attachments.” The link is hereby added; http://oamp.od.nih.gov/DGS/FORMS/sectionk.pdf

SECTION 2 – QUESTIONS AND RESPONSES

This section of the amendment provides questions submitted by potential applicants/offerors and the responses provided by NIAID. The responses are offered for information only and do not modify or become part of this solicitation. This Amendment will be updated as needed to add further questions and their related responses. All potential offerors are advised to refer back to Amendment 1 for additional Questions & Answers.

Question 1: Will the BAA support mapping of overlapping T-cell and B-cell epitopes?

Answer: The primary purpose of this initiative is to provide support to establish highly interactive, multi-disciplinary teams whose research efforts are focused on large scale discovery of T cell epitopes associated with microorganisms responsible for emerging and re-emerging infectious diseases and potential agents of bioterrorism and their toxins (listed as NIAID Emerging and re-Emerging Infectious Diseases at http://www.niaid.nih.gov/topics/emerging/Pages/list.aspx. Research conducted under this initiative shall include one or more types to T cell epitope discovery. (found in Attachments 5, section 1 – Research Design).

http://oamp.od.nih.gov/DGS/FORMS/sectionk.pdf http://www.niaid.nih.gov/topics/emerging/Pages/list.aspx

Amendment #2 to BAA-NIAID-DAIT-NIHAI2013167